Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Ian@SI who wrote (3464)	4/19/2001 4:10:14 PM
From: Jibacoa	Read Replies (1) \| Respond to of 52153

Yes, QLT finished higher in spite of Canadians stocks going lower.<g> "Gaining ground were shares of QLT Inc. (CA:QLT: news, alerts) after the biotech company received European approval to market its Visudyne product for treatment of severe near-sightedness. The news earned the company an upgrade from Research Capital, which boosted its rating on the stock to "hold" from "reduce." QLT shares rose C$2.10, or 6.7 percent, to C$33.35." ORCH closed up 11.81% on volume of 425,000 and closing B/A of 4/2 Bernard